HEYU BIO TECH Revenue, Profits - HYBT Quarterly Income Statement

Add to My Stocks
$2.35 $0 (0%) HYBT stock closing price Aug 17, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q1
HEYU BIO TECH Revenues or Net Sales
-
Cost Of Goods Sold (COGS)-
HEYU BIO TECH Gross Profit
-
Research & Development Expense-
Selling General & Admin Expense-
Income Before Depreciation Depletion Amortization-
Depreciation Depletion Amortization-
Non Operating Income-
Interest Expense-
HEYU BIO TECH Pretax Income
-0.01M
Provision for Income Taxes-
MinorityInterest-
Investment Gains Losses-
Other Income-
Income Before Extraordinaries & Disc Operations-0.01M
Extraordinary Items & Discontinued Operations-
HEYU BIO TECH Profit/ Loss (Net Income)
-0.01M
Average Shares used to compute Diluted EPS-
Average Shares used to compute Basic EPS-
Income Before Nonrecurring Items-
Income from Nonrecurring Items-
HEYU BIO TECH Earnings Per Share Basic Net
-0.03
HEYU BIO TECH Earnings Per Share Diluted Net
-0.03
EPS Diluted Before Nonrecurring Items-
Preferred Dividends Acc Pd-
Dividends Common0.00
Dividend Per Share Common0.00
All figures in USD. M: Millions of USD, B: Billions of USD.

HEYU BIO TECH Income Statement - Key Financial Ratios

Dividend Yield
0%

Other Income Statements - HEYU BIO TECH Industry Peers

Bitzio income statement, Cannasys income statement, TigerLogic income statement